NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--May 1, 2006--BrainStorm Cell Therapeutics (OTCBB:BCLI - News) announced today that it has appointed Joy A. Cavagnaro, Ph.D., DABT, RAC as Safety Consultant. BrainStorm is developing stem cell therapeutic products for the treatment of neurodegenerative diseases.
